Browsing by Author "Tucker, Matthew"
Results Per Page
Sort Options
Item Open Access Accelerating Implementation of Virtual Care in an Integrated Health Care System: Future Research and Operations Priorities.(Journal of general internal medicine, 2021-08) Lewinski, Allison A; Sullivan, Caitlin; Allen, Kelli D; Crowley, Matthew J; Gierisch, Jennifer M; Goldstein, Karen M; Gray, Kaileigh; Hastings, Susan N; Jackson, George L; McCant, Felicia; Shapiro, Abigail; Tucker, Matthew; Turvey, Carolyn; Zullig, Leah L; Bosworth, Hayden BBackground
Virtual care is critical to Veterans Health Administration (VHA) efforts to expand veterans' access to care. Health care policies such as the Veterans Access, Choice, and Accountability (CHOICE) Act and the Maintaining Internal Systems and Strengthening Integrated Outside Networks (MISSION) Act impact how the VHA provides care. Research on ways to refine virtual care delivery models to meet the needs of veterans, clinicians, and VHA stakeholders is needed.Objective
Given the importance of virtual approaches for increasing access to high-quality VHA care, in December 2019, we convened a Think Tank, Accelerating Implementation of Virtual Care in VHA Practice, to consider challenges to virtual care research and practice across the VHA, discuss novel approaches to using and evaluating virtual care, assess perspectives on virtual care, and develop priorities to enhance virtual care in the VHA.Methods
We used a participatory approach to develop potential priorities for virtual care research and activities at the VHA. We refined these priorities through force-ranked prioritization and group discussion, and developed solutions for selected priorities.Results
Think Tank attendees (n = 18) consisted of VHA stakeholders, including operations partners (e.g., Office of Rural Health, Office of Nursing Services, Health Services Research and Development), clinicians (e.g., physicians, nurses, psychologists, physician assistants), and health services researchers. We identified an initial list of fifteen potential priorities and narrowed these down to four. The four priorities were (1) scaling evidence-based practices, (2) centralizing virtual care, (3) creating high-value care within the VHA with virtual care, and (4) identifying appropriate patients for virtual care.Conclusion
Our Think Tank took an important step in setting a partnered research agenda to optimize the use of virtual care within the VHA. We brought together research and operations stakeholders and identified possibilities, partnerships, and potential solutions for virtual care.Item Open Access Acute Myeloid Leukemia After Olaparib Treatment in Metastatic Castration-Resistant Prostate Cancer.(Clinical genitourinary cancer, 2017-12) Zhu, Jason; Tucker, Matthew; Wang, Endi; Grossman, Joel S; Armstrong, Andrew J; George, Daniel J; Zhang, TianItem Open Access Creation of an Autonomous, Fluorescence-Based Tissue Diagnostic and Ablation Device for use in Brain Tumor Resection(2020) Tucker, MatthewPhysical resection of tumors is a crucial component of the treatment of brain tumors. Traditionally, a multi-faceted approach involving resection as well as chemotherapy and radiation provide the backbone for most modern brain tumor treatment strategies. The process of tumor location and removal routinely involves the use of a number of sensory modalities (such as pre-operative MRIs and CT scans) and manual resection tools (such as electrocautery and forceps). Unfortunately, this current paradigm offers hurdles that stand in the way of more precise, accurate tumor resection. These hurdles include the physical phenomenon of brain shift and the natural limitation of the human hand placement in surgery. Due to the well documented relationship between extent of resection of brain tumor and survivability, there is a need to overcome these hurdles for more precise surgical resection. This dissertation presents a device that aims to increase the accuracy and precision of tumor removal surgery. This integrated system involves a non-contact laser induced fluorescence device, called the TumorID, and the previously documented TumorCNC. The TumorID utilizes a 405 nm laser to induce fluorescence that is collected by the device and quantified by an attached CCD spectrometer. The quantified spectral data is passed to a trained classifier that classifies the data as healthy or tumorous. The designation is passed to the TumorCNC. Based on the designation and sensory data, the TumorCNC generates an ablation path and removes tissue using a CO2 laser. The TumorID is capable of classifying melanoma brain metastasis, glioma, and healthy tissue with 100% accuracy based on ex vivo mouse brain tissue. The total integrated system is capable of ablating the boundary of a tumor mimicking tissue phantom with a RMSE of 1.69 mm. Therefore, on average for the entire tumor boundary, the device only deviates from the actual tumor boundary by approximately 1.5 mm. Reports have indicated that human surgeons can achieve accuracy on the order of approximately 0.3 mm. Therefore, the system is still short of the reported accuracy of a human surgeon. However, future research steps include the incorporation of a more sophisticated search strategy, implementation of a classifier that utilizes the boundary as a class in the mutli-class classifier, and decreasing the spot size of the CO2 laser. All of these potential avenues have the potential to increase the accuracy and precision of the tumor removal abilities of the non-contact, integrated system.
Item Open Access Creation of Non-Contact Device for Use in Metastatic Melanoma Margin Identification in ex vivo Mouse Brain.(Proceedings of SPIE--the International Society for Optical Engineering, 2022-01) Tucker, Matthew; Lacayo, Matthew; Joseph, Suzanna; Ross, Weston; Chongsathidkiet, Pakawat; Fecci, Peter; Codd, Patrick JBecause contemporary intraoperative tumor detection modalities, such as intraoperative MRI, are not ubiquitously available and can disrupt surgical workflow, there is an imperative for an accessible diagnostic device that can meet the surgeon's needs in identifying tissue types. The objective of this paper is to determine the efficacy of a novel non-contact tumor detection device for metastatic melanoma boundary identification in a tissue-mimicking phantom, evaluate the identification of metastatic melanoma boundaries in ex vivo mouse brain tissue, and find the error associated with identifying this boundary. To validate the spatial and fluorescence resolution of the device, tissue-mimicking phantoms were created with modifiable optical properties. Phantom tissue provided ground truth measurements for fluorophore concentration differences with respect to spatial dimensions. Modeling metastatic disease, ex vivo melanoma brain metastases were evaluated to detect differences in fluorescence between healthy and neoplastic tissue. This analysis includes determining required-to-observe fluorescence differences in tissue. H&E staining confirmed tumor presence in mouse tissue samples. The device detected a difference in normalized average fluorescence intensity in all three phantoms. There were differences in fluorescence with the presence and absence of melanin. The estimated tumor boundary of all tissue phantoms was within 0.30 mm of the ground truth tumor boundary for all boundaries. Likewise, when applied to the melanoma-bearing brains from ex vivo mice, a difference in normalized fluorescence intensity was successfully detected. The potential prediction window for the tumor boundary location is less than 1.5 mm for all ex vivo mouse brain tumors boundaries. We present a non-contact, laser-induced fluorescence device that can identify tumor boundaries based on changes in laser-induced fluorescence emission intensity. The device can identify phantom ground truth tumor boundaries within 0.30 mm using instantaneous rate of change of normalized fluorescence emission intensity and can detect endogenous fluorescence differences in melanoma brain metastases in ex vivo mouse tissue.Item Open Access Group physical therapy for knee osteoarthritis: protocol for a hybrid type III effectiveness-implementation trial.(Implementation science communications, 2023-10) Webb, Sara; Drake, Connor; Coffman, Cynthia J; Sullivan, Caitlin; Sperber, Nina; Tucker, Matthew; Zullig, Leah L; Hughes, Jaime M; Kaufman, Brystana G; Pura, John A; Anderson, Livia; Hastings, Susan N; Van Houtven, Courtney H; Abbate, Lauren M; Hoenig, Helen; Ballengee, Lindsay A; Wang, Virginia; Allen, Kelli DBackground
Knee osteoarthritis (OA) is a leading cause of chronic pain and disability and one of the most common conditions treated in outpatient physical therapy (PT). Because of the high and growing prevalence of knee OA, there is a need for efficient approaches for delivering exercise-based PT to patients with knee OA. A prior randomized controlled trial (RCT) showed that a 6-session Group Physical Therapy Program for Knee OA (Group PT) yields equivalent or greater improvements in pain and functional outcomes compared with traditional individual PT, while requiring fewer clinician hours per patient to deliver. This manuscript describes the protocol for a hybrid type III effectiveness-implementation trial comparing two implementation packages to support delivery of Group PT.Methods
In this 12-month embedded trial, a minimum of 16 Veterans Affairs Medical Centers (VAMCs) will be randomized to receive one of two implementation support packages for their Group PT programs: a standard, low-touch support based on Replicating Effective Programs (REP) versus enhanced REP (enREP), which adds tailored, high-touch support if sites do not meet Group PT adoption and sustainment benchmarks at 6 and 9 months following launch. Implementation outcomes, including penetration (primary), adoption, and fidelity, will be assessed at 6 and 12 months (primary assessment time point). Additional analyses will include patient-level effectiveness outcomes (pain, function, satisfaction) and staffing and labor costs. A robust qualitative evaluation of site implementation context and experience, as well as site-led adaptations to the Group PT program, will be conducted.Discussion
To our knowledge, this study is the first to evaluate the impact of tailored, high-touch implementation support on implementation outcomes when compared to standardized, low-touch support for delivering a PT-based intervention. The Group PT program has strong potential to become a standard offering for PT, improving function and pain-related outcomes for patients with knee OA. Results will provide information regarding the effectiveness and value of this implementation approach and a deeper understanding of how healthcare systems can support wide-scale adoption of Group PT.Trial registration
This study was registered on March 7, 2022 at ClinicalTrials.gov (identifier NCT05282927 ).Item Open Access Mandated caregiver training in the Veterans Health Administration: Caregiver inquiry informs national dissemination.(The Gerontologist, 2022-11) Sperber, Nina R; Boucher, Nathan; Hughes, Jaime M; Bruening, Rebecca; Zullig, Leah L; Decosimo, Kasey; Tucker, Matthew; Christensen, Leah A; Allen, Kelli D; Hastings, Susan N; Van Houtven, Courtney HBackground and objectives
A minority of family caregivers receive training, with implications for their own and their recipient's outcomes. Federal policy has supported implementation and expansion of caregiver training and support. The Department of Veterans Affairs (VA) has developed a national Caregiver Support Program and collaborated with VA health services researchers to explore caregivers' acceptance of an evidence-based training program in preparation for system-wide dissemination.Research design and methods
This approach entailed a convergent mixed-methods design, which involved separate analyses of quantitative and qualitative data. Survey questions based on the Kirkpatrick model for training evaluation measured caregivers' reaction and learning and interview questions elicited caregivers' reports about the value of the program for them.Results
Most caregivers reported satisfaction with the training when responding to survey questions, although qualitative interviews revealed caveats suggesting need to hone the best timing and specific group of caregivers for maximal benefit.Discussion and implications
Our findings indicate that understanding program-user fit may be particularly critical when implementing training for caregivers as they come to the program at different points along their caregiving journey, needing differing types and intensities of support. While a general program may appeal to policymakers aiming to scale caregiver training within a large, heterogeneous system, there may be shortcomings in terms of end-user acceptance and subsequent downstream outcomes such as reach and ultimately program effectiveness. Good, iterative communication flow between program developers and policymakers facilitates this understanding and, in turn, decisions about scaling.Item Open Access Ready, set, go! The role of organizational readiness to predict adoption of a family caregiver training program using the Rogers' diffusion of innovation theory.(Implementation science communications, 2023-06) Van Houtven, Courtney H; Drake, Connor; Malo, Teri L; Decosimo, Kasey; Tucker, Matthew; Sullivan, Caitlin; D'Adolf, Josh; Hughes, Jaime M; Christensen, Leah; Grubber, Janet M; Coffman, Cynthia J; Sperber, Nina R; Wang, Virginia; Allen, Kelli D; Hastings, S Nicole; Shea, Christopher M; Zullig, Leah LBackground
Caregivers FIRST is an evidence-based program addressing gaps in caregivers' skills. In 2020, the Veterans Health Administration Caregiver Support Program (CSP) nationally endorsed Caregivers FIRST, offering credit in leadership performance plans to encourage all VA medical centers (VAMCs) to implement locally. This study examines the association of organizational readiness with VAMC adoption of Caregivers FIRST.Methods
In a cohort observational study, we surveyed CSP managers about their facilities' readiness to implement using the Organizational Readiness for Implementing Change (ORIC) instrument and compared change commitment and change efficacy domains among VAMCs "adopters" defined as delivering Caregivers FIRST within 1 year of the national announcement to those that did not ("non-adopters"). Within "adopters," we categorized time to adoption based on Rogers' diffusion of innovation theory including "innovators," "early adopters," "early majority," "late adopters," and "laggards." Organizational readiness and site characteristics (facility complexity, staffing levels, volume of applications for caregiver assistance services) were compared between "adopters," "non-adopters," and between time to adoption subcategories. Separate logistic regression models were used to assess whether ORIC and site characteristics were associated with early adoption among "adopters."Results
Fifty-one of 63 (81%) VAMCs with CSP manager survey respondents adopted Caregivers FIRST during the first year. ORIC change commitment and efficacy were similar for "adopters" and "non-adopters." However, sites that adopted earlier (innovators and early adopters) had higher ORIC change commitment and efficacy scores than the rest of the "adopters." Logistic regression results indicated that higher ORIC change commitment (odds ratio [OR] = 2.57; 95% confidence interval [CI], 1.11-5.95) and ORIC change efficacy (OR = 2.60; 95% CI, 1.12-6.03) scores were associated with increased odds that a VAMC was an early adopter (categorized as an "innovator," "early adopter", or "early majority"). Site-level characteristics were not associated with Caregivers FIRST early adoption.Conclusions
To our knowledge, this study is the first to prospectively assess organizational readiness and the timing of subsequent program adoption. Early adoption was associated with higher ORIC change commitment and change efficacy and not site-level characteristics. These findings yield insights into the role of organizational readiness to accelerate program adoption.Trial registration
ClinicalTrials.gov, NCT03474380. Registered on March 22, 2018.